Sapere Bio

Sapere Bio is an early-stage laboratory services company developing a diagnostic test that will guide physicians to select treatments and therapies that maximize patient outcome. This blood test will determine a patient’s “molecular age” and improve risk assessment and patient outcome. Sapere Bio was founded based on intellectual property from the laboratory of Dr. Norman Sharpless, at the Lineberger Comprehensive Cancer Center, in the UNC School of Medicine-Chapel Hill.